Q Chip Ltd expanded its ReaX range of enhanced PCR products by the introduction of ReaX beads for the detection of bacterial and viral hospital acquired infections (HAIs). The product portfolio currently includes assays for MRSA, Klebsiella, and Pseudomonas with tests for norovirus, Clostridium difficile and Vancomycin Resistant Enterococcus (VRE) scheduled for launch early next year.
A single bead is a complete PCR assay in an easy-to-use format with a much simplified workflow compared to some currently available molecular diagnostic tests.
The ReaX MRSA bead contains a multiplex end-point PCR assay to identify antibiotic (mecA) resistant Staphylococcus aureus. The ReaX beads for Klebsiella and Pseudomonas contain all the assay components including the probes & primers for a real time PCR assay. The format for the norovirus assay is a two step RT PCR assay consisting of two beads: an RT ReaX bead and a qPCR bead.
The ReaX HAI bead product range is not currently regulated, however, the assays and manufacturing capability are available for license.
The ReaX format offers an alternative to lyophilisation as a stability technology for molecular applications.
Filed Under: Drug Discovery
